Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (1464)	2/19/2007 8:23:09 AM
From: finbar	Read Replies (1) \| Respond to of 1475

FWIW - there a reason that BTRN still trades around a nickel+ While there are no employees or active business, they still own a chunk of Stem Cell Sciences stock which now publicly trades on the AIM in London, more importantly they still have retained milestone and royalty rights for Medi-507 which Medimmune is advancing through trials, and for which they have reported very favorable results to date. A liquidator files status reports a few times a year in the bk court for Mass.